REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Pim Pharmaceuticals (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Pim Pharmaceuticals Profile Updated: November 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

PT Pim Pharmaceuticals is an enterprise in Indonesia, with the main office in Sidoarjo. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on April 12, 2026. 300 (estimated) employees currently work for PT Pim Pharmaceuticals. From the latest financial highlights, PT Pim Pharmaceuticals reported a net sales revenue increase of 12.31% in 2024. Over the same period, its total assets grew by 11.09%.

Headquarters
Kav 21 - Kahuripan Nirwana
Sidoarjo; East Java; Postal Code: 61228

Contact Details: Purchase the PT Pim Pharmaceuticals report to view the information.

Website: http://www.pimpharma.com

Basic Information
Total Employees:
Purchase the PT Pim Pharmaceuticals report to view the information.
Registered Capital:
Purchase the PT Pim Pharmaceuticals report to view the information.
Financial Auditors:
Purchase the PT Pim Pharmaceuticals report to view the information.
Incorporation Date:
April 12, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Pim Pharmaceuticals report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
12.31%
Total Operating Revenue
12.31%
Total Assets
11.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?